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IL-1 beta(FIP) is an invariably fatal disease of cats caused by systemic infection with a
feline coronavirus (FCoV) termed feline infectious peritonitis virus (FIPV). The lethal pathology associated
with FIP (granulomatous inﬂammation and T-cell lymphopenia) is thought to be mediated by aberrant
modulation of the immune system due to infection of cells such as monocytes and macrophages.
Overproduction of pro-inﬂammatory cytokines occurs in cats with FIP, and has been suggested to play a
signiﬁcant role in the disease process. However, the mechanism underlying this process remains unknown.
Here we show that infection of primary blood-derived feline mononuclear cells by FIPV WSU 79-1146 and
FIPV-DF2 leads to rapid activation of the p38 MAPK pathway and that this activation regulates production of
the pro-inﬂammatory cytokine tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta).
FIPV-induced p38 MAPK activation and pro-inﬂammatory cytokine production was inhibited by the pyridinyl
imidazole inhibitors SB 203580 and SC 409 in a dose-dependent manner. FIPV-induced p38 MAPK activation
was observed in primary feline blood-derived mononuclear cells individually puriﬁed from multiple SPF cats,
as was the inhibition of TNF-alpha production by pyridinyl imidazole inhibitors.
© 2008 Elsevier Inc. All rights reserved.Introduction
Coronaviruses are a diverse family of enveloped positive-stranded
RNA viruses that infect a wide range of species including humans.
Coronaviruses are divided into three groups in which group 1 and 2
infect mammals and group 3 infects birds (Perlman et al., 2008). Feline
coronaviruses (FCoVs) belongs to group 1 and are classiﬁed as either
serotype I or II depending on the sequence of their spike (S) protein
(Rottier, 1999). In addition, each serotype is divided into two biotypes
designated as either feline enteric coronavirus (FECV) or feline
infectious peritonitis virus (FIPV) based on their pathological outcome
in cats (Vennema et al., 1998). FECV is ubiquitous amongst felines and
causes mild to often unapparent enteritis, while FIPV leads to a lethal
systemic infection marked by severe granulomatous inﬂammation
(Pedersen et al., 1984a, 1984b; Weiss and Scott, 1981). The mechanism
underlying this drastic difference in disease between the two biotypes
remains elusive, namely because FECV and FIPV isolates from the
same serotype are virtually indistinguishable on the genetic and
antigenic level. However it has been shown that the two biotypes
possess markedly different abilities to infect cells of the immunel rights reserved.system, with FIPV isolates possessing an extended tropism that allows
for the infection of macrophages and monocytes (Stoddart and Scott,
1989). Recent studies have suggested that this alteration in tropism
may be due to mutations in the S protein that affect protein cleavage
and fusion activation during entry (Regan et al., 2008; Rottier et al.,
2005).
Viral pathogens that infect immune cells (e.g. human immunode-
ﬁciency virus (HIV) and Dengue Virus) are known to induce aberrant
cytokine production, a process which is proposed to play a role in the
pathological outcome of their respective diseases (Fantuzzi et al.,
2003; Kedzierska and Crowe, 2002; Leong et al., 2007). Studies of cats
with FIP have shown that cytokine expressions are altered as
compared to healthy animals (Dean et al., 2003; Kiss et al., 2004).
Speciﬁcally it has been noted that expression of the pro-inﬂammatory
cytokine tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta
(IL-1 beta) and interleukin-6 (IL-6) are signiﬁcantly increased in cats
with FIP, and are likely produced by infected macrophages and
monocytes (Kiss et al., 2004; Takano et al., 2007a, 2007b). It has been
shown that TNF-alpha is able to induce feline T-cell apoptosis, making
it the most likely causative agent of T-cell lymphopenia in FIPV-
infected cats (Dean et al., 2003; Takano et al., 2007a). In addition TNF-
alpha has been shown to increase expression of the FCoV receptor
aminopeptidase N (APN) causing target cells to be more susceptible to
viral infection and further exacerbate the disease (Takano et al.,
Fig. 1. FIPV induces phosphorylation of p38 MAPK in PFBM cells. PFBM cells were
infected with either untreated FIPV-1146 or FIPV-DF2 viral particles (A), or UV-
inactivated particles (B), at anMOI of 100. Cells were lysed at the speciﬁed times p.i. and
analyzed by western blot with the anti-phospho-p38 MAPK mAb (3D7) and re-probed
with anti-p38 MAPK (N-20) pAb. Signal intensity from two time-course infections of
untreated FIPV-1146 and one time-course infection of untreated FIPV-DF2 were
quantiﬁed by densitometry analysis with Image J software (C).
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outcome of FIP, the mechanism regulating FIPV-induced upregulation
of pro-inﬂammatory cytokines remains undescribed.
Mitogen-activated protein kinases (MAPKs) are a family of proteins
that serve as components of signaling pathways within cells in order
to process and respond to extracellular stimuli (Raman et al., 2007).
Typically, receptors on the cell surface initiate signaling cascades,
which lead to phosphorylation and translocation of MAPKs to the
nucleus where they regulate transcriptional activators (Whitmarsh,
2007). In recent years, it has become clear that MAPKs also regulate
processes outside of the nucleus such as mRNA translation and
cytoskeletal remodeling (Frevel et al., 2003; Huang et al., 2004). Three
majorMAPK pathways have been identiﬁedwhich are conserved in all
eukaryotic cells ranging from yeast to mammals. These pathways are
designated as Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2),
c-Jun N-terminal Kinases (JNK1) and p38 MAPK (Pearson et al., 2001).
In general the ERK pathway is activated by proliferative stimuli, while
the JNK and p38 MAPK pathways are activated by extracellular
stresses such as ultraviolet light, heat and osmotic shock (Pearson et
al., 2001). p38MAPKwas originally identiﬁed as the target of pyridinyl
imidazole compounds that were shown to inhibit the production of IL-
1 and TNF-alpha in lipopolysaccharide (LPS)-stimulated human
monocytes (Lee et al., 1994). Subsequent studies have shown that
the p38 MAPK pathway is responsible for the phosphorylation of a
large group of transcriptional and translational response elements
which directly regulate the expression of a wide variety of pro-
inﬂammatory cytokines (Kumar et al., 2003).
Due to its involvement in cytokine regulation, we reasoned that
the p38 MAPK pathway might play a role in the increased production
of pro-inﬂammatory cytokines observed in cats with FIP. In this study
we examined the activation of the p38 MAPK pathway in response to
infection by FIPV in primary feline blood-derived mononuclear cells.
We also investigated the role of p38 MAPK in TNF-alpha, IL-1 beta and
IL-6 production, and the effect of p38 MAPK inhibitors on these
processes.
Results
Activation of the p38 MAPK pathway during FIPV infection
The p38 MAPK pathway has been shown to be activated by
multiple viral pathogens during infection (Adamson et al., 2000;
Banerjee et al., 2002; Dumitru et al., 2006; Erhardt et al., 2002;
Holloway and Coulson, 2006; Zachos et al., 1999). To determine
whether the p38MAPK pathway is activated during the infectious life-
cycle of FIPV, primary feline blood-derived mononuclear (PFBM) cells
were inoculated with either FIPV-1146 or FIPV-DF2 at an MOI of 100.
Untreated cells and infected cells ranging from 15min to 12 h p.i. were
lysed and analyzed by western blot with the anti-phospho-p38 MAPK
mAb (3D7). Untreated cells showed a minimal level of p38 MAPK
phosphorylation, however addition of either virus isolate caused rapid
phosphorylation of p38 MAPK (N600% increase) within 15 min p.i.
(Figs. 1A and C). p38 MAPK underwent dephosphorylation by 60 min
and then showed a second phase of phosphorylation later in infection
between 6 and 12 h p.i., which was less pronounced (Fig. 1A). To
determine whether viral replication was required for FIPV-induced
p38 MAPK activation, UV-inactivated virus was added to PFBM cells
and analyzed by western blot as described above (Fig. 1B). UV-treated
FIPV also induced p38 MAPK phosphorylation, however the activation
was not biphasic, and instead remain sustained throughout the 12 h
time-course (Fig. 1B). Membranes were re-probed with anti-p38
MAPK (N-20) pAb to show that an equal amount of p38 MAPK was
present in each sample (Figs. 1A and B). To further conﬁrm that the
p38 MAPK pathway is activated by FIPV, PFBM cells were inoculated
with FIPV-1146 at an MOI of 100 before ﬁxing the cells for
immunoﬂuorescent microscopy. p38 MAPK again showed a rapidphosphorylation by 15 min p.i. while the total amount of p38 MAPK
remained unchanged (Fig. 2). In addition the p38 MAPK in infected
cells showed increased nuclear localization as compared to untreated
cells, a phenomenon highly associated with the regulation of
transcriptional activators (Fig. 2). These data indicate that the p38
MAPK pathway is activated during infection of PFBM cells by FIPV, and
that viral replication is dispensable for this activation to occur.
Effect of pyridinyl imidazole inhibitors on FIPV-induced p38 MAPK
activation
The p38 MAPK pathway was ﬁrst discovered by investigating the
target of pyridinyl imidazole compounds which blocked LPS-induced
cytokine induction in human monocytes (Lee et al., 1994). To test the
effect of pyridinyl imidazole inhibitors on FIPV-induced p38 MAPK
phosphorylation, PFBM cells were treated with 10 μM of either SB
203580 or SC 409 (or 0.1% DMSO as a control) for 2 h before
inoculating with FIPV-1146 or FIPV-DF2 at an MOI of 100. 15 min p.i.
cells were lysed and analyzed by western blot with the anti-phospho-
p38 MAPK mAb (3D7). Cells which were pretreated with DMSO alone
Fig. 2. Immunoﬂuorescence of FIPV-induced p38MAPK activation and nuclear re-localization. PFBM cells were infectedwith FIPV-1146 at anMOI of 100. Cells were ﬁxed at 15min p.i.
and stained with the anti-phospho-p38 MAPK mAb (3D7), the anti-p38 MAPK (N-20) pAb and Hoechst.
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those which were pretreated with either SB 203580 or SC 409 showed
no activation as compared to uninfected cells (Fig. 3). These data
demonstrate that FIPV-induced p38 MAPK activation is blocked by
pyridinyl imidazole inhibitors.
FIPV replication is not affected by inhibition of the p38 MAPK pathway
Activation of the p38MAPKpathwayhas been shown to be required
for replication of some viruses including the murine coronavirus
Mouse Hepatitis Virus (MHV) (Banerjee et al., 2002). To investigate
whether activation of the p38 MAPK pathway is required for
replication of FIPV, PFBM cells were treated with 10 μM of either SB
203580 or SC 409 (or 0.1%DMSO as a control) for 2 h before inoculating
with FIPV-1146 or FIPV-DF2. 12 h p.i. cells were ﬁxed and stained for
with the anti-FIPV N protein mAb (17B7.1). As shown in Fig. 4,
pretreatment with p38 MAPK inhibitors has no signiﬁcant effect on
FIPV replication in PFBM cells.Fig. 3. Inhibition of FIPV-induced p38 MAPK activation in PFBM cells by the pyridinyl
imidazole compounds SB 203580 and SC 409. PFBM cells were pretreated with 10 μMof
either SB 203580 or SC 409 (or 0.1% DMSO as a control) for 2 h before inoculating with
FIPV-1146 or FIPV-DF2 at an MOI of 100. 15 min p.i. cells were lysed and analyzed by
western blot with the anti-phospho-p38MAPKmAb (3D7) and re-probedwith anti-p38
MAPK (N-20) pAb.TNF-alpha production is regulated by FIPV-induced p38 MAPK activation
Activation of p38 MAPK by viral pathogens has been shown to
induce the production of pro-inﬂammatory cytokines such as TNF-
alpha, IL-1 beta and IL-6 (Banerjee et al., 2002; Griego et al., 2000;
Lee et al., 2005a, 2005b; Sloan and Jerome, 2007; Wang et al.,
2004; Yurochko and Huang, 1999). To investigate whether TNF-
alpha production in FIPV-infected PFBM cells is regulated by p38
MAPK activation, PFBM cells were treated with 10 μM of either SB
203580, SC 409 or 0.1% DMSO for 2 h before inoculating with FIPV-
1146 or FIPV-DF2 at an MOI of 100. 24 h p.i. supernatants were
collected, concentrated and analyzed by western blot with the anti-
TNF-alpha (N-19) pAb. Cells which were pretreated with DMSO
alone showed signiﬁcant production of TNF-alpha, however those
which were pretreated with either SB 203580 or SC 409 showed no
detectable production of TNF-alpha as compared to uninfected cells
(Fig. 5A). To quantify the production of TNF-alpha, infections were
performed as described above, except at 24 h p.i. supernatants were
collected and analyzed by anti-TNF-alpha capture ELISA. Infected
cells which were pretreated with DMSO alone showed signiﬁcant
production of TNF-alpha (N750 pg/ml) however pretreatment with
10 μM SB 203580 and 10 μM SC 409 resulted in a 8-fold and 4-fold
reduction in TNF-alpha production respectively (Fig. 5B). Uninfected
cells produced no TNF-alpha, or were below the detection level of
the assay (data not shown). Overall these data indicate that
production of the pro-inﬂammatory cytokine TNF-alpha in FIPV-
infected PFBM cells is regulated by activation of the p38 MAPK
pathway.
p38 MAPK inhibitors reduce TNF-alpha production in a dose-dependent
manner
To show that the reduction of FIPV-induced TNF-alpha produc-
tion by SB 203580 and SC 409 was speciﬁc to the pyridinyl
imidazole inhibitors, PFBM cells were treated with either SB 203580
or SC 409 at a range of concentrations (10 μM, 1 μM or 0.1 μM) or
0.1% DMSO for 2 h before inoculating with FIPV-1146 or FIPV-DF2 at
an MOI of 100. As seen in our previous data, PFBM cells which were
pretreated with DMSO alone produced signiﬁcant amounts of TNF-
alpha however pretreatment with SB 203580 and SC 409 resulted in
a signiﬁcant reduction in TNF-alpha production in a dose-dependent
manner (Fig. 6).
Fig. 4. Inhibition of the p38 MAPK pathway does not signiﬁcantly affect FIPV infection of PFBM cells. PFBM cells were pretreated with 10 μM of either SB 203580 or SC 409 (or 0.1%
DMSO as a control) for 2 h before inoculating with FIPV-1146 or FIPV-DF2. Cells were ﬁxed 12 h p.i. and stained with the anti-FIPV-N proteinmAb (17B7.1) (A). For quantiﬁcation, N500
cells were scored from three independent replicates of each experimental condition (B). Error bars represent the standard deviation of the mean.
Fig. 5. FIPV-induced TNF-alpha production by PFBM cells is regulated by p38 MAPK
activation. PFBM cells were pretreated with 10 μM of either SB 203580 or SC 409 (or
0.1% DMSO as a control) for 2 h before inoculating with FIPV-1146 or FIPV-DF2 at anMOI
of 100. 24 h p.i. supernatants were collected, concentrated and analyzed bywestern blot
with the anti-TNF-alpha (N-19) pAb (A). 24 h p.i. supernatants were collected and TNF-
alpha production was quantiﬁed by anti-TNF-alpha capture ELISA (B). TNF-alpha
produced from untreated cells was below the detection limit of the assay (b10 pg/ml).
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multiple cats
It is known that individual animals can vary in their reaction to
infection by FIPV (Kiss et al., 2004). To determinewhether or not FIPV-
induced p38 MAPK activation was speciﬁc to a single animal, PFBM
cells were individually prepared from six additional SPF cats (07PGP2,
07PGV4, 07PGV5, 07FGR2, 07FGV6, 07FJM5). PFBM cells individually
puriﬁed from each animal were inoculated with FIPV-1146 at an MOI
of 100. Untreated cells and infected cells (15 min p.i.) were lysed andFig. 6. FIPV-induced TNF-alpha production is inhibited in a dose-dependent manner by
SB 203580 and SC 409. PFBM cells were pretreated with either SB 203580 or SC 409 at a
range of concentrations (10 μM,1 μMor 0.1 μM) or 0.1% DMSO for 2 h before inoculating
with FIPV-1146 at an MOI of 100. 24 h p.i. supernatants were collected and TNF-alpha
production was quantiﬁed by anti-TNF-alpha capture ELISA. TNF-alpha from untreated
cells was below the detection limit of the assay (b10 pg/ml).
Fig. 7. FIPV-induced p38 MAPK activation in PFBM cells from six individual SPF cats. PFBM cells were individually prepared from three male (07PGP2, 07PGV4, 07PGV5) and three
female (07FGR2, 07FGV6, 07FJM5) SPF cats. Cells from each animal were inoculatedwith FIPV-1146 at anMOI of 100.15min p.i. cells were lysed and analyzed bywestern blot with the
anti-phospho-p38 MAPK mAb (3D7) and re-probed with anti-p38 MAPK (N-20) pAb.
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(3D7). Consistent with our previous data, untreated cells showed a
minimal level of p38 MAPK phosphorylation while addition of FIPV
caused a rapid phosphorylation of p38MAPK in PFBM cells from all six
cats (Fig. 7). Membranes were re-probed with anti-p38 MAPK (N-20)
pAb to show that an equal amount of p38 MAPK was present in each
sample (Fig. 7). In addition, the regulation of TNF-alpha production by
p38 MAPKwas analyzed in PFBM cells from all six SPF cats. PFBM cells
from each animal were treated with 10 μM SC 409 or 0.1% DMSO for
2 h before inoculating with FIPV-1146 at an MOI of 100. 24 h p.i.
supernatants were collected and analyzed by anti-TNF-alpha capture
ELISA. While the baseline level of TNF-alpha production differed
slightly amongst all of the cats tested, treatment with the p38
inhibitor SC 409 resulted in the same trend observed in our previous
experiments: a signiﬁcant reduction in TNF-alpha levels (between 3-
fold to 8-fold) (Fig. 8). These data taken together suggest that FIPV-
induced activation of the p38 MAPK pathway in PFBM cells represents
a common mechanism by which this virus promotes TNF-alpha
production in cats.
IL-1 beta production is regulated by FIPV-induced p38 MAPK activation
Cats with FIP have also been reported to show increased levels of
the pro-inﬂammatory cytokines IL-1 beta and IL-6. To investigate
whether IL-1 beta and IL-6 production in FIPV-infected PFBM cells is
regulated by p38 MAPK activation, PFBM cells were treated with
10 μM of either SB 203580, SC 409 or 0.1% DMSO for 2 h before
inoculating with FIPV-1146 at an MOI of 100. 24 h p.i. supernatants
were collected and analyzed by anti-IL-1 beta and anti-IL-6 capture
ELISA. Infected cells which were pretreated with DMSO alone showed
signiﬁcant production of IL-1 beta (N200 pg/ml) however pretreat-
ment with 10 μM SB 203580 and 10 μM SC 409 resulted in a 7-fold and
4-fold reduction in IL-1 beta production respectively (Fig. 9). Neither
infected nor uninfected PFBM cells produced signiﬁcant levels of IL-6
(Fig. 9). Overall, these data indicate that both TNF-alpha and IL-1 beta
production in FIPV-infected PFBM cells is regulated by p38 MAPK
activation, a situation that does not apply to IL-6.
Discussion
Modulation of signaling pathways by viruses is becoming
recognized as a key pathogenic determinant in viral diseasesmediatedby aberrant host immunological responses. In the case of FIP, cytokine
production is markedly altered between animals with disease as
compared to healthy animals, with overproduction of the pro-
inﬂammatory cytokine TNF-alpha in particular being indicative of a
poor outcome (Kiss et al., 2004). Feline TNF-alpha causes apoptosis in
feline T-cells (implicating it as the causative agent of T-cell
lymphopenia), and upregulates the FIPV receptor APN making target
cells more susceptible to infection in vitro (Dean et al., 2003; Kiss et al.,
2004; Takano et al., 2007a, 2007b). It has been shown previously that
FIPV-infected monocytes upregulate the expression of TNF-alpha,
however the mechanism regulating this process remains undescribed.
In this study we show that infection by FIPV causes a rapid activation
the p38 MAPK pathway in PFBM cells, and that this process directly
regulates production of the pro-inﬂammatory cytokines TNF-alpha
and IL-1 beta.
As shown in Fig.1, FIPV-induced p38MAPK activation in PFBM cells
occurs in a biphasic temporal pattern which mimics that observed
with other viral pathogens that activate MAPK pathways during
infection such as inﬂuenza virus (Pleschka et al., 2001). At present we
are unable to deﬁne themechanism bywhich FIPV particles are able to
activate the p38 MAPK pathway, however the rapid nature of the
initial activation suggests that it occurs early during entry; likely due
to interactions between the S protein and its receptor. This model is
further supported by the observation that UV-inactivated virus also
induce rapid activation of the p38 MAPK pathway. This activation is
markedly different than that reported in MHV infected cells, where
activation did not occur until 6–12 h p.i., and UV-treated viral particles
did not induce phosphorylation of p38 MAPK (Banerjee et al., 2002). It
notable that the FIPV receptor APN localizes to lipid rafts (Navarrete
Santos et al., 2000; Nomura et al., 2004) which are known to be a
signaling portal for the p38 MAPK pathway (Calzolari et al., 2006;
Head et al., 2006; Olsson and Sundler, 2006; Sugawara et al., 2007;
Wang et al., 2006; Zeidan et al., 2008). In fact it has recently been
shown that rhinovirus activates the p38 MAPK pathway through the
actions of lipid rafts and RhoA (Dumitru et al., 2006). Further
investigation will be necessary to determine the role of APN and
lipid rafts in the initial phase of FIPV-induced p38 MAPK activation
and TNF-alpha/IL-1 beta production.
Interestingly, UV-inactivated FIPV induced prolonged p38 MAPK
activation, rather than the biphasic activation induced by untreated
viral particles. This suggests that FIPV may activate p38 MAPK during
entry, but then suppresses p38 MAPK during the early phase of
Fig. 8. FIPV-induced TNF-alpha production by PFBM cells from six SPF cats is inhibited by SC 409. PFBM cells were individually prepared from three male (07PGP2, 07PGV4, 07PGV5)
and three female (07FGR2, 07FGV6, 07FJM5) SPF cats. Cells from each animal were inoculated with FIPV-1146 at an MOI of 100. 24 h p.i. supernatants were collected and TNF-alpha
production was quantiﬁed by anti-TNF-alpha capture ELISA. TNF-alpha from untreated cells was below the detection limit of the assay (b10 pg/ml).
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induced by untreated viral particles (6 h p.i.) may be caused by the
production of pro-inﬂammatory cytokines. It has been shown that
TNF-alpha can itself activate the p38 MAPK through signaling
associated with the cytoplasmic domain of its receptors TNF receptor
1 (TNFR1)-associated death domain protein (TRADD) and TNF
receptor-associated factor 2 (TRAF2) (Carpentier et al., 1998; Hsu etal., 1995,1996). Therefore TNF-alpha produced during the initial phase
of FIPV-induced p38 MAPK activation, may be the cause of the latter
phase of activation.
Pretreatment with the pyridinyl imidazole inhibitors SB 203580
and SC 409 blocked production of TNF-alpha and IL-1 beta suggesting
that p38 MAPK directly regulates production of the cytokines in FIPV-
infected PFBM cells. The upregulation of IL-6 production was not
Fig. 9. Production of IL-l beta and IL-6 by FIPV-infected PFBM cells. PFBM cells were pretreated with 10 μM of either SB 203580 or SC 409 (or 0.1% DMSO as a control) for 2 h before
inoculating with FIPV-1146 at an MOI of 100. 24 h p.i. supernatants were collected and IL-1 beta and IL-6 production was quantiﬁed by anti-IL-1 beta or anti-IL-6 capture ELISA.
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typemay be responsible for its production in cats with FIP. At this time
the mechanism by which p38 MAPK regulates pro-inﬂammatory
cytokine production in FIPV-infected PFBM cells is unknown, however
regulation of cytokines by MAPKs in analogous systems occurs by
affecting either transcriptional regulation, translational regulation, or
both (Kumar et al., 2003). For example the recently emerged severe
acute respiratory syndrome coronavirus (SARS-CoV) is also known to
inﬁltrate immune cells such as monocytes and macrophages and
activate the p38 MAPK pathway (Belyavsky et al., 1998; Franks et al.,
2003; Gu et al., 2005; Nicholls et al., 2003). SARS-CoV infection causes
a p38 MAPK-dependent phosphorylation of downstream transcrip-
tional regulators such as activating transcription factor 1 (ATF-1) and
signal transducer and activator of transcription 3 (STAT-3), as well as
translational regulators such as MAPK activate protein kinase 2
(MAPKAPK2) and the eukaryotic initiation factor 4E (eIF4E) (Mizutani,
2007; Mizutani et al., 2004a, 2004b). As seen in Fig. 2 it appears that
FIPV causes increased p38 MAPK nuclear localization suggesting that
the activation of transcription factors likely play a role in pro-
inﬂammatory production in PFBM cells, however this also does not
exclude a role for translational regulation. Future studies examining
the role of downstream transcriptional and translational regulators in
FIPV-infected PFBM cells should clarify the mechanism regulating this
process.
Another aspect complicating the treatment of FIP is the diverse
reactions to infection displayed by cats with the disease (Kiss et al.,
2004). Our results suggest that activation of the p38 MAPK pathway
and its regulation of TNF-alpha production is common to PFBM cells of
all cats, however further sampling of animals throughout different
geographic regions will be required to conﬁrm this conclusion.
Pyridinyl imidazole compounds have been shown to be efﬁcacious
therapeutic agents for blocking themediators of chronic inﬂammatory
diseases such as rheumatoid arthritis (Kumar et al., 2003). In fact,
several p38 MAPK inhibitors have shown promise in animal models of
inﬂammatory diseases and some have even reached human clinical
trials (Kumar et al., 2003). Our results show a clear activation of p38MAPK by FIPV during infection, and that this activation is responsible
for pro-inﬂammatory cytokine production which is a key contributor
to the pathological changes observed in cats with FIP. This raises this
possibility that p38 MAPK inhibitors, alone or in conjunction with
other therapies, may possess therapeutic beneﬁts in the treatment of
cats with FIP.
Materials and methods
Cells
Primary feline blood-derived mononuclear (PFBM) cells were
individually puriﬁed from four male SPF cats (animal ID# 07PJO7,
07PGP2, 07PGV4, 07PGV5) and three female SPF cats (animal ID#
07FGR2, 07FGV6, 07FJM5) (Liberty Research, Waverly, NY) using a
standard Ficoll-paque gradient (GE Healthcare) as speciﬁed by the
manufacturer. Cells were seeded in 24-well plates with tissue culture-
treated glass coverslips and allowed to attach overnight. After
washing, cells were incubated in the presence of 5% CO2 at 37 °C in
RPMI-1640 media pH7.4 supplemented with 10% Fetal Bovine Serum
(FBS), 2 mM glutamine, 100 U/ml penicillin and 10 μg/ml streptomy-
cin. The purity of PFBM preparations were routinely checked by
immunoﬂuorescence microscopy using the marker DH59B (Veter-
inary Medical Research & Development Inc., Pullman, WA). Crandell-
Reese Feline Kidney cells were obtained from the American Type
Culture Collection (ATCC) and cultured and maintained according to
ATCC guidelines.
Viruses
FIPV WSU 79-1146 (FIPV-1146) was obtained from the ATCC. FIPV-
DF2 was provided by Dr. Ed Dubovi (Animal Health Diagnostic Center,
New York State College of Veterinary Medicine, Cornell University).
Both viruses were grown by inoculating CRFK cells at a MOI of 0.01
and collecting supernatant after CPE was observed in 80% of cells
which typically occurred between 48 and 72 h. Supernatant was
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viral particles were then pelleted by centrifugation at 28,000 rpm in a
SW28 rotor (Sorvall) for 60 min. Pellets were resuspended in
phosphate-buffered saline (PBS). Virus titers were determined by
plaque assays on CRFK cells using standard techniques. For UV-
inactivation, a thin layer of viral suspension was exposed to UV light
(30 W) at a distance of 10 cm for 5 min. Inactivation was veriﬁed by
performing infection assays in CRFK and PFBM cells as described.
Antibodies and inhibitors
The anti-phospho-p38 MAPK (Thr180/Tyr182) (3D7) rabbit mono-
clonal antibody (mAb) was obtained from Cell Signaling Technologies
(Danvers, MA). The anti-p38 MAPK (N-20) goat polyclonal antibody
(pAb) and anti-TNF-alpha (N-19) goat pAb were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). The anti-FIPV nucleocapsid (N)
protein mAb (17B7.1) was provided by Dr. Ed Dubovi (Animal Health
Diagnostic Center, New York State College of Veterinary Medicine,
Cornell University). Anti-CD127a mAb DH59B was obtained from
Veterinary Medical Research and Development, Inc. (Pullman, WA).
The feline TNF-alpha ELISA kit (TNF-alpha/TNFSF1A), feline IL-1 beta
ELISA kit (IL-1 beta/IL-1F2), feline IL-6 ELISA kit, and associated
antibodies and detection reagents were obtained from R&D Systems
(Minneapolis, MN). The p38 MAPK inhibitors 4-(4-Fluorophenyl)-2-
(4-methylsulﬁnylphenyl)-5-(4-pyridyl)1H-imidazole (SB 203580) and
4-(3-(4-Chlorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl)
pyrimidine (SC 409) were obtained from Calbiochem (San Diego, CA).
Infection assays
PFBM cells were incubated in low-serum media (1% FBS) for 12 h
before inoculation with the speciﬁed virus at an MOI of 100, or
pretreatmentwith the speciﬁed inhibitor for 2 h followed by infection.
For p38MAPK activation experiments, cells were lysed at the speciﬁed
time-points in lysis buffer (1% Triton X-100, 50 mM Tris–HCl, 150 mM
NaCl, 1 mM EDTA, 1 mM DTT, 50 mM beta-glycerophosphate, 100 mM
sodium vanadate, pH 7.4) supplemented with 1× complete protease
inhibitor cocktail (Roche). Lysates were clariﬁed by centrifugation at
13,000 rpm in a table-top centrifuge at 4 °C for 15 min before freezing
at −80 °C for later analysis. For immunoﬂuorescence assays, cells were
ﬁxed at the speciﬁed time-points with 3% paraformaldehyde. For
analysis of cytokine production, supernatant was collected 24 h post-
inoculation (p.i.) before freezing at −80 °C for later analysis.
Immunoﬂuorescence microscopy
Fixed cells were labeled with the speciﬁed antibodies as described
previously (Chu et al., 2006). Cells were viewed on a Nikon Eclipse
E600 ﬂuorescence microscope, and images were captured with a
Sensicam EM camera and analyzed with IPLab software.
Western blot and ELISA
SDS sample buffer was added to lysates and the reaction was
heated at 95 °C for 10 min before separation using a 4–20% SDS-PAGE
gel at 200 V for 2 h. Gels were electroblotted to PVDF membrane at
200 A for 2 h, blocked with 5% bovine serum albumin and probed with
the speciﬁed antibody at 4 °C for 12 h. Membranes were developed
using either anti-rabbit antibody (Southern Biotech, Birmingham AL)
or anti-goat antibody (Santa Cruz Biotechnology, Santa Cruz CA)
linked to horseradish peroxidase and ECL substrate (Pierce, Rockford
IL) and images captured using a Fujiﬁlm LAS-3000 CCD camera. For
western blot analysis of TNF-alpha production, supernatants were
concentrated 50× using iCon 9 kDa molecular weight cut-off spin
columns (Pierce, Rockford IL) and analyzed by western blot as
described above. Western blot densitometry analysis of signalintensity was performed using ImageJ software. For quantiﬁcation of
cytokine production, supernatants were processed with the speciﬁed
ELISA kits (R&D Systems) using standard capture ELISA techniques as
speciﬁed by the manufacturer.
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